1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Srinivas Devarakonda: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Daratumumab - Recurrent Plasma Cell Myeloma | Phase 2 | Terminated | Srinivas Devarakonda | 1 | 2020-12-22 | 2023-09-28 |
Multiple Myeloma (1)
Cyclophosphamide (1) · Melphalan (1) · Mycophenolic Acid (1) · Stem Cell Transplantation (1) · Tacrolimus (1) · daratumumab (1) · fludarabine (1)
United States (1)